Drug Markets/Cholestyramine

Cholestyramine

24 NDCs across 8 manufacturers|24 Generic,0 Brand

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved May 26, 1988. FDA's Orange Book lists 32 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $19 million on Cholestyramine across 198,000 claims for 84,000 beneficiaries.

Cholestyramine is available as 24 NDCs from 8 manufacturers (24 generic, 0 brand), with NADAC prices from $0.64 to $0.80 per EAa 26% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

24

24G / 0B

Manufacturers

8

competing in market

Price Spread

$0.64 – $0.80

per EA, 12 of 24 NDCs

7d Activity

1653 flat

avg +6.0% WoW · of 24 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

24 NDCs total, 24 shown

Drug Price 7d Change
CHOLESTYRAMINE LIGHT PACKET
$0.8034
per EA
-0.20%
CHOLESTYRAMINE LIGHT PACKET
$0.8034
per EA
-0.20%
PREVALITE PACKET
$0.8034
per EA
-0.20%
CHOLESTYRAMINE LIGHT PACKET
$0.8034
per EA
-0.20%
PREVALITE PACKET
$0.8034
per EA
-0.20%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.7724
per EA
+14.93%
CHOLESTYRAMINE PACKET
$0.6370
per EA
CHOLESTYRAMINE LIGHT POWDER
$0.2841
per GM
+0.41%
PREVALITE POWDER
$0.1621
per GM
+6.91%
CHOLESTYRAMINE LIGHT POWDER
$0.1621
per GM
+6.91%
CHOLESTYRAMINE LIGHT POWDER
$0.1454
per GM
CHOLESTYRAMINE LIGHT POWDER
$0.1265
per GM
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%
CHOLESTYRAMINE POWDER
$0.0946
per GM
+3.32%

Frequently Asked Questions

When did Cholestyramine become available as a generic?

FDA approved the first generic Cholestyramine (ANDA) on May 26, 1988. The Orange Book currently lists 32 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Cholestyramine?

In 2024, Medicare Part D spent $19 million on Cholestyramine across 198,000 claims for 84,000 beneficiaries.

How many Cholestyramine products are on the market?

The Cholestyramine drug market contains 24 NDCs from 8 manufacturers — 24 generic and 0 brand products.

What is the price range for Cholestyramine?

NADAC reference prices for Cholestyramine range from $0.6370 to $0.8034 per EA — a 26% difference between cheapest and most expensive. 12 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.

Which manufacturers make Cholestyramine?

8 manufacturers list Cholestyramine in NADAC. Ranked by number of NDCs, the largest are Zydus Pharmaceuticals (USA) Inc. (4), Endo USA Inc. (4), Upsher-Smith Laboratories LLC (3), Precision Dose Inc. (3), PuraCap Laboratories LLC (3).

How has the price of Cholestyramine changed recently?

Over the past 7 days, 16 Cholestyramine NDCs rose and 5 fell, with a market-wide average change of +6.0%.